StageSeed - II | Alive
Aeonvital focuses on the development of new personalized tumor immunotherapy products. Aeonvital mainly has two core technology platforms, one is a TILs cell therapy development platform for solid tumors; the other is a therapeutic nucleic acid vaccine development platform for precancerous lesions caused by HPV infection and cervical cancer. The company's products include cellular immunotherapy products and nucleic acid therapeutic vaccine products. The company was founded in 2021 and is based in Beijing, China.
Missing: Aeonvital's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Aeonvital's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Aeonvital Frequently Asked Questions (FAQ)
When was Aeonvital founded?
Aeonvital was founded in 2021.
Where is Aeonvital's headquarters?
Aeonvital's headquarters is located at Sihai Huachen Building, No. 33 Tianhua Street, Daxing District, Beijing.
What is Aeonvital's latest funding round?
Aeonvital's latest funding round is Seed - II.
Who are the investors of Aeonvital?
Investors of Aeonvital include Duowen Capital, Tianyu Healthcare Investment and Jintan Capital.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.